Tech Company Financing Transactions

Castle Creek Biosciences Funding Round

Paragon Biosciences, Fidelity Management & Research Company and Horizon Technology Finance participated in a $75 million funding round for Castle Creek Biosciences. The round was announced on 3/27/2020.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

405 Eagleview Blvd.
Exton, PA 19341
USA

Phone

(484) 713-6000

Website

www.castlecreekbio.com

Email Address

[email protected]

Overview

Castle Creek Biosciences, Inc., a gene therapy company, is focused on delivering transformative therapies for patients living with rare and serious diseases with high unmet needs. Our approach to personalized biologics is distinctive based on our autologous proprietary fibroblast technology.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Maslowski

        

Chief Medical Officer

Mary Spellman

        

Chief Operating Officer

Babar Ghias

        

VP - Bus. Development

Sean Buckley

        

VP - Bus. Development

Gregory Wujek

        

Browse more venture capital transactions:

Prev: 3/27/2020: ReCode Therapeutics venture capital transaction
Next: 3/27/2020: SutroVax venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary